Skip to main navigation Skip to search Skip to main content

In vitro replication capacity of HIV-2 variants from long-term aviremic individuals

  • Hetty Blaak
  • , Marchina E. van der Ende
  • , Patrick H. M. Boers
  • , Hanneke Schuitemaker
  • , Albert D. M. E. Osterhaus

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

To establish whether efficient suppression of virus replication in HIV-2-infected individuals is associated with low replicative capacity of HIV-2, replication kinetics of HIV-2 variants from long-term aviremic individuals was analyzed and compared with that of the relatively slow-replicating HIV-1 variants from asymptomatics and long-term nonprogressors (AS/LTNP). On average, HIV-2 from aviremic individuals had lower replication rates than HIV-1 variants from AS/LTNP in cells of 8 donors (0.45 log10 [range 0.14-0.77] vs. 0.58 log10 [range 0.32-0.99] pg RT/ml/day, P = 0.036). The relatively low replication rate of HIV-2 compared to HIV-1 variants was not related to different sensitivities to inhibition by CD8+ T cells or different degrees of infectivity. HIV-2 replication rates increased with progressive infection and with switch from CCR5 to CXCR4 usage. The relatively low replicative capacity of HIV-2 variants from aviremic individuals likely contributes to the low viral load and benign course of infection in these individuals
Original languageEnglish
Pages (from-to)144-154
JournalVirology
Volume353
Issue number1
DOIs
Publication statusPublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'In vitro replication capacity of HIV-2 variants from long-term aviremic individuals'. Together they form a unique fingerprint.

Cite this